JP2006524698A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006524698A5 JP2006524698A5 JP2006513239A JP2006513239A JP2006524698A5 JP 2006524698 A5 JP2006524698 A5 JP 2006524698A5 JP 2006513239 A JP2006513239 A JP 2006513239A JP 2006513239 A JP2006513239 A JP 2006513239A JP 2006524698 A5 JP2006524698 A5 JP 2006524698A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US46584103P | 2003-04-25 | 2003-04-25 | |
| PCT/US2004/012510 WO2004096136A2 (en) | 2003-04-25 | 2004-04-23 | Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006524698A JP2006524698A (ja) | 2006-11-02 |
| JP2006524698A5 true JP2006524698A5 (cg-RX-API-DMAC10.html) | 2007-02-08 |
Family
ID=33418301
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006513239A Pending JP2006524698A (ja) | 2003-04-25 | 2004-04-23 | カチオン性微粒子およびｈｃｖｅ１ｅ２ｄｎａを含有する組成物ならびにその使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20070264285A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP1622566A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2006524698A (cg-RX-API-DMAC10.html) |
| CN (1) | CN1809584B (cg-RX-API-DMAC10.html) |
| AU (1) | AU2004233851B2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA2523266A1 (cg-RX-API-DMAC10.html) |
| NZ (1) | NZ543343A (cg-RX-API-DMAC10.html) |
| RU (1) | RU2364419C2 (cg-RX-API-DMAC10.html) |
| WO (1) | WO2004096136A2 (cg-RX-API-DMAC10.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0602637D0 (en) * | 2006-02-09 | 2006-03-22 | Glaxo Group Ltd | Novel process |
| CA2804591C (en) * | 2010-07-06 | 2019-01-22 | Novartis Ag | Cationic oil-in-water emulsions |
| WO2013053481A1 (de) * | 2011-10-11 | 2013-04-18 | Secutech International Pte. Ltd. | Dimethylsulfoxid als lösungsmittel für nukleinsäuren |
| RU2675108C2 (ru) * | 2015-06-15 | 2018-12-17 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт биомедицинской химии имени В.Н. Ореховича" (ИБМХ) | Композиция на основе синтетических пептидов и липидов для вакцины против гепатита с |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE52535B1 (en) * | 1981-02-16 | 1987-12-09 | Ici Plc | Continuous release pharmaceutical compositions |
| US6207646B1 (en) * | 1994-07-15 | 2001-03-27 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules |
| AU3241095A (en) * | 1994-07-29 | 1996-03-04 | Chiron Corporation | Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |
| US6884435B1 (en) * | 1997-01-30 | 2005-04-26 | Chiron Corporation | Microparticles with adsorbent surfaces, methods of making same, and uses thereof |
| PT1042001E (pt) * | 1997-12-16 | 2002-09-30 | Chiron Corp | Uso de microparticulas combinadas com emulsoes submicronicas oleo-em-agua |
| WO2000011140A1 (en) * | 1998-08-20 | 2000-03-02 | The Wistar Institute Of Anatomy And Biology | Methods of augmenting mucosal immunity through systemic priming and mucosal boosting |
| WO2000050006A2 (en) * | 1999-02-26 | 2000-08-31 | Chiron Corporation | Microemulsions with adsorbed macromoelecules and microparticles |
| US7329408B2 (en) * | 1999-12-01 | 2008-02-12 | Novartis Vaccines And Diagnostics, Inc. | Eliciting HCV-specific antibodies |
| WO2002026212A2 (en) * | 2000-09-28 | 2002-04-04 | Chiron Corporation | Microparticle compositions and methods for the manufacture thereof |
| US20030138453A1 (en) * | 2000-09-28 | 2003-07-24 | O'hagan Derek | Microparticles for delivery of heterologous nucleic acids |
| ES2399386T3 (es) * | 2001-04-05 | 2013-04-01 | Novartis Vaccines And Diagnostics, Inc. | Aumento de la inmunidad de las mucosas tras sensibilización parenteral |
| AU2002322358B2 (en) * | 2001-06-29 | 2009-06-18 | Novartis Vaccines And Diagnostics, Inc. | HCV E1E2 vaccine compositions |
| EP1576125A4 (en) * | 2002-10-25 | 2008-09-03 | Novartis Vaccines & Diagnostic | ACTIVATION OF SPECIFIC HCV LYMPHOCYTES |
-
2004
- 2004-04-23 WO PCT/US2004/012510 patent/WO2004096136A2/en not_active Ceased
- 2004-04-23 US US10/554,625 patent/US20070264285A1/en not_active Abandoned
- 2004-04-23 CN CN2004800171762A patent/CN1809584B/zh not_active Expired - Fee Related
- 2004-04-23 RU RU2005136668/13A patent/RU2364419C2/ru not_active IP Right Cessation
- 2004-04-23 AU AU2004233851A patent/AU2004233851B2/en not_active Ceased
- 2004-04-23 NZ NZ543343A patent/NZ543343A/en not_active IP Right Cessation
- 2004-04-23 JP JP2006513239A patent/JP2006524698A/ja active Pending
- 2004-04-23 CA CA002523266A patent/CA2523266A1/en not_active Abandoned
- 2004-04-23 EP EP04750507A patent/EP1622566A4/en not_active Ceased
-
2011
- 2011-03-18 US US13/051,217 patent/US20110177110A1/en not_active Abandoned